CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Watanabe, K. [1 ]
Okuma, Y. [1 ]
Nakahara, Y. [1 ]
Yomota, M. [1 ]
Takagi, Y. [1 ]
Hosomi, Y. [1 ]
Okamura, T. [1 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt460.21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [42] IS PEMETREXED EFFECTIVE FOR THE ACTIVATING EGFR MUTATION-POSITIVE NON-SQUAMOUS NON-SMALL-CELL CANCER?
    Kozuki, T.
    Nogami, N.
    Toyozawa, R.
    Katou, Y.
    Shinkai, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 136 - 137
  • [43] A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
    Iwasaku, M.
    Hattori, Y.
    Morita, S.
    Yoshioka, H.
    Otsuka, K.
    Katakami, N.
    Fujita, S.
    Yokota, S.
    Imamura, F.
    Negoro, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 422 - 422
  • [44] A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
    Namba, Y.
    Hattori, Y.
    Edagawa, M.
    Yoshioka, H.
    Iwasaku, M.
    Shimada, T.
    Satouchi, M.
    Katagami, N.
    Fujita, S.
    Mori, M.
    Imamura, F.
    Kotani, Y.
    Nishimura, T.
    Morita, S.
    Negoro, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 86
  • [45] A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
    Hattori, Yoshihiro
    Satouchi, Miyako
    Kotani, Yoshikazu
    Yoshioka, Hiroshige
    Iwasaku, Masahiro
    Katakami, Nobuyuki
    Fujita, Shiro
    Otsuka, Kojiro
    Yokota, Soichiro
    Namba, Yoshinobu
    Imamura, Fumio
    Nishimura, Takashi
    Fujita, Kanako
    Morita, Satoshi
    Negoro, Shunichi
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S489
  • [46] Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non-small-cell lung cancer
    Kaira, Kyoichi
    Ono, Akihiro
    Kamide, Yosuke
    Sunaga, Noriaki
    Koga, Yasuhiko
    Saitoh, Jun-ichi
    Shirai, Katsuyuki
    Ebara, Takeshi
    Hisada, Takeshi
    Ishizuka, Tamotsu
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (02) : 228 - 233
  • [47] Doublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapy
    Nakashima, Kazuhisa
    Murakami, Haruyasu
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Endo, Masahiro
    Takahashi, Toshiaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (05) : 575 - 578
  • [48] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer
    Karayama, Masato
    Inui, Naoki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Yokomura, Koshi
    Koshimizu, Naoki
    Sato, Masaki
    Toyoshima, Mikio
    Shirai, Toshihiro
    Masuda, Masafumi
    Yamada, Takashi
    Imokawa, Shiro
    Suda, Takafumi
    EUROPEAN JOURNAL OF CANCER, 2016, 58 : 30 - 37
  • [49] Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer
    Laktionov, K.
    Smolin, A.
    Stroyakovskiy, D.
    Moiseenko, V.
    Dvorkin, M.
    Andabekov, T.
    Cheng, Y.
    Liu, B.
    Kozlov, V.
    Odintsova, S.
    Dvoretsky, S.
    Mochalova, A.
    Urda, M.
    Yi, T.
    Li, X.
    Laszlo, U.
    Mueller, V.
    Bogos, K.
    Fadeeva, N.
    Musaev, G.
    Liu, Q.
    Kirtbaya, D.
    Shi, J.
    Gladkov, O.
    Narimanov, M.
    Semiglazova, T.
    Khasanova, A.
    Chovanec, J.
    Andrasina, I
    Szabova, A.
    Rosinska, O.
    Sudekova, D.
    Zsolt, P. -s.
    Ran, F.
    Sun, M.
    Jiang, O.
    Chen, R.
    Zhao, E.
    Liu, C.
    Tan, W.
    Pirmagomedov, A.
    Poddubskaya, E.
    Kislov, N.
    Shumskaya, I.
    Sorokina, I.
    Zinkina-Orikhan, A.
    Linkova, Yu.
    Fogt, S.
    Liaptseva, D.
    Siliutina, A.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [50] Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    LANCET, 2021, 397 (10274): : 557 - 559
12345